Company page
Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker ALGS. The company focuses on developing innovative therapies for viral infections and liver diseases. As of now, Aligos Therapeutics has a market capitalization of approximately $32.67 million.
- Ticker
- ALGS:NASDAQ
- Asset type
- Stock
- Market cap
- $32.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD